Moret EE - Search Results

1

Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery.

van de Wetering P, Moret EE, Schuurmans-Nieuwenbroek NM, van Steenbergen MJ, Hennink WE. van de Wetering P, et al. Among authors: moret ee. Bioconjug Chem. 1999 Jul-Aug;10(4):589-97. doi: 10.1021/bc980148w. Bioconjug Chem. 1999. PMID: 10411456

2

Conformation and intermolecular interactions of SA2 peptides self-assembled into vesicles.

van Hell AJ, Klymchenko A, Burgers PP, Moret EE, Jiskoot W, Hennink WE, Crommelin DJ, Mastrobattista E. van Hell AJ, et al. Among authors: moret ee. J Phys Chem B. 2010 Sep 2;114(34):11046-52. doi: 10.1021/jp103440d. J Phys Chem B. 2010. PMID: 20687533

3

Lipophilicity of a series of cytostatic aziridinyl quinones.

De Boer M, Moret EE, Janssen LH, Holthuis JJ, Driebergen RJ, Reinhoudt DN, Verboom W. De Boer M, et al. Among authors: moret ee. Prog Clin Biol Res. 1989;291:87-90. Prog Clin Biol Res. 1989. PMID: 2726893 No abstract available.

4

In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.

Moret EE, de Boer M, Hilbers HW, Tollenaere JP, Janssen LH, Holthuis JJ, Driebergen RJ, Verboom W, Reinhoudt DN. Moret EE, et al. J Med Chem. 1996 Feb 2;39(3):720-8. doi: 10.1021/jm9405147. J Med Chem. 1996. PMID: 8576915

5

Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.

Mooney CA, Johnson SA, 't Hart P, Quarles van Ufford L, de Haan CA, Moret EE, Martin NI. Mooney CA, et al. Among authors: moret ee. J Med Chem. 2014 Apr 10;57(7):3154-60. doi: 10.1021/jm401977j. Epub 2014 Mar 31. J Med Chem. 2014. PMID: 24649802

6

Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis.

Swaan PW, Koops BC, Moret EE, Tukker JJ. Swaan PW, et al. Among authors: moret ee. Recept Channels. 1998;6(3):189-200. Recept Channels. 1998. PMID: 10100327

7

Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.

van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ. van Hattum H, et al. Among authors: moret ee. J Med Chem. 2013 Feb 14;56(3):1350-4. doi: 10.1021/jm301677r. Epub 2013 Jan 23. J Med Chem. 2013. PMID: 23281927

8

Major histocompatibility complex class II binding characteristics of peptoid-peptide hybrids.

de Haan EC, Wauben MH, Grosfeld-Stulemeyer MC, Kruijtzer JA, Liskamp RM, Moret EE. de Haan EC, et al. Among authors: moret ee. Bioorg Med Chem. 2002 Jun;10(6):1939-45. doi: 10.1016/s0968-0896(01)00434-5. Bioorg Med Chem. 2002. PMID: 11937352

9

Structure-based design and evaluation of MHC class II binding peptides.

de Haan EC, Wauben MH, Grosfeld-Stulemeyer MC, Moret EE. de Haan EC, et al. Among authors: moret ee. Biologicals. 2001 Sep-Dec;29(3-4):289-92. doi: 10.1006/biol.2001.0296. Biologicals. 2001. PMID: 11851330

10

Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites.

van Haren M, van Ufford LQ, Moret EE, Martin NI. van Haren M, et al. Among authors: moret ee. Org Biomol Chem. 2015 Jan 14;13(2):549-60. doi: 10.1039/c4ob01734j. Org Biomol Chem. 2015. PMID: 25380215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters